Avalon GloboCare Corp. financial data

Symbol
ALBT on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
4400 Route 9, Suite 3100, Freehold, New Jersey
State of incorporation
Delaware
Fiscal year end
December 31
Former names
GLOBAL TECHNOLOGIES CORP (to 10/11/2016)
Latest financial report
Q1 2024 - May 31, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 14.4 % -71.9%
Debt-to-equity 110 % +3.44%
Return On Equity -126 % +11.9%
Return On Assets -60 % +13.5%
Operating Margin -1.09 K % -38.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 11.1 M shares +9.25%
Common Stock, Shares, Outstanding 11.1 M shares +9.25%
Entity Public Float 7.4 M USD -52.1%
Common Stock, Value, Issued 1.12 K USD +8.77%
Weighted Average Number of Shares Outstanding, Basic 11 M shares +10.1%
Weighted Average Number of Shares Outstanding, Diluted 11 M shares +10.1%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 1.27 M USD +6.11%
Research and Development Expense 0 USD -100%
Costs and Expenses -60.7 K USD -15.9%
Operating Income (Loss) -13.8 M USD -47%
Nonoperating Income (Expense) -1.31 M USD +61.4%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -15.2 M USD -18.6%
Net Income (Loss) Attributable to Parent -15.2 M USD -18.6%
Earnings Per Share, Basic -1.42 USD/shares -5.97%
Earnings Per Share, Diluted -1.42 USD/shares -5.97%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 305 K USD
Other Assets, Current 62 K USD +65.1%
Assets, Current 778 K USD -44.1%
Deferred Income Tax Assets, Net 149 K USD +25.1%
Property, Plant and Equipment, Net 35.7 K USD -74.5%
Operating Lease, Right-of-Use Asset 103 K USD -53.4%
Intangible Assets, Net (Excluding Goodwill) 9.23 M USD
Other Assets, Noncurrent 226 K USD -40.2%
Assets 20.3 M USD -34.1%
Accounts Payable, Current 102 K USD
Liabilities, Current 7.8 M USD +50.7%
Operating Lease, Liability, Noncurrent 4.86 K USD
Liabilities 14.3 M USD +29.1%
Accumulated Other Comprehensive Income (Loss), Net of Tax -235 K USD -12%
Retained Earnings (Accumulated Deficit) -81.1 M USD -23%
Stockholders' Equity Attributable to Parent 6.05 M USD -69.4%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 6.05 M USD -69.4%
Liabilities and Equity 20.3 M USD -34.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -916 K USD +50.1%
Net Cash Provided by (Used in) Financing Activities 937 K USD +24.9%
Net Cash Provided by (Used in) Investing Activities -20.2 K USD -1054%
Common Stock, Shares Authorized 490 M shares 0%
Common Stock, Shares, Issued 11.2 M shares +9.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 20.1 K USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 305 K USD -65.6%
Interest Paid, Excluding Capitalized Interest, Operating Activities 239 K USD +80.9%
Deferred Tax Assets, Valuation Allowance 17.3 M USD +13.8%
Deferred Tax Assets, Gross 22 M USD +26.2%
Operating Lease, Liability 110 K USD
Depreciation 44.5 K USD -27.1%
Payments to Acquire Property, Plant, and Equipment 20.2 K USD +1054%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -15.2 M USD -18.4%
Lessee, Operating Lease, Liability, to be Paid 114 K USD -53.1%
Property, Plant and Equipment, Gross 155 K USD -62%
Operating Lease, Liability, Current 110 K USD -9.41%
Lessee, Operating Lease, Liability, to be Paid, Year Two 4.9 K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 114 K USD -17.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 4.3 K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 11.4 K USD +93.6%
Deferred Tax Assets, Operating Loss Carryforwards 15.5 M USD +13.6%
Preferred Stock, Shares Authorized 105 K shares -99%
Additional Paid in Capital 67.9 M USD
Share-based Payment Arrangement, Expense 54.7 K USD -50.5%
Interest Expense 229 K USD +392%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%